Study regarding the effect of ayurvedic decoction in heart disease

Randomized controlled clinical study to evaluate the efficacy of Pushkarmuladi kwath as an adjuvant therapy in vataj hridrog with special reference to stable angina - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065234

Enrollment

Registered

2024-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I208- Other forms of angina pectoris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with signs and symptoms of Stable Angina e.g chest pain, palpitation, sweating, fatigue,vertigo 2)Patient who met NYHA (New York Heart Association) criteria for Angina(Grade I,II and III)

Exclusion criteria

Exclusion criteria: 1) Patients who had previous revascularization CABG(Coronary Artery Bypass Graft), PTCA (Percutaneous Transluminal Coronary Angioplasty) stenting. 2) Patients being evaluated for other cardiac diseases except stable angina(e.g valvular disease, etiology of cardiomyopathy, Myocardial infraction, Evidence of heart failure) 3) Pregnant woman and lactating mother.. 4) Other major co-existing illnesses like chronic anemia, malignancy, renal or hepatic disease, stroke, auto-immune diseases. 5) Refusal to give informed consent. 6) Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C or patients taking immunosupressive drugs

Design outcomes

Primary

Measure	Time frame
Improvement in Stress test (trade mill test)Timepoint: 45 days	—

Secondary

Measure	Time frame
Improvement in lipid profile and ECGTimepoint: 45 days	—

Countries

India

Contacts

Public ContactVd Harish Garge

Ayurved Seva Sanghas Ayurved Mahavidyalaya Nashik

drhgarge@gmail.com9405366160

Outcome results